In this context, the optimal cocktail therapy that consisted of IFN-α, GM-CSF, and recombinant HBV vaccine (VACCINE) was tested in a mouse model using recombinant adeno-associated virus 8 (AAV8)-1.3HBV infection. Here, CSF2 is linked to infection.